Human Accountability in an Agentic Pharma World

About this episode

Amrit Moola discusses the operationalization of AI in pharma and biotech with Srivatsan Nagaraja.

Vertex senior director Amrit Moola sits down with Srivatsan Nagaraja to discuss what it takes to operationalize AI in pharma and biotech from early experiments to large‑scale transformation. He describes how to pick high‑impact use cases, re‑architect processes around agents and real‑time data, and align business operations on outcomes. The discussion ranges from CRO recruitment data and batch disposition in cell and gene therapy to guardrails, governance, and why you can’t blame the algorithm when something goes wrong.

People in this episode

Host: Srivatsan Nagaraja

Guest: Amrit Moola

Topics covered

• AI in pharma
• biotech transformation
• operationalizing AI
• business operations
• data governance

Keywords

• AI
• pharma
• biotech
• data
• governance
• CRO recruitment
• cell therapy
• gene therapy

Mentioned in this episode

Organizations: Vertex

More episodes of Life Sciences DNA Podcast

• Lessons from Insmed’s Journey to an AI First Biotech · June 11, 2026 · 46 min
• Making AI Transformations that Stick · May 14, 2026 · 53 min
• Finding ROI from AI in the Mundane · April 9, 2026 · 46 min
• A Pragmatic Path to AI-Enabled Commercial Operations · March 26, 2026 · 37 min
• Reimagining Scientific Work in the Age of AI Agents · March 12, 2026 · 47 min
• Orchestrating Scientists, Data, and AI to Discover New Drugs · February 26, 2026 · 46 min